Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0NF0Q
|
||||
| Former ID |
DIB012456
|
||||
| Drug Name |
ZD-0947
|
||||
| Synonyms |
AZD-0947
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Overactive bladder disorder [ICD9: 188, 596.51; ICD10:C67, N32.81] | Discontinued in Phase 2 | [546657] | ||
| Company |
AstraZeneca plc
|
||||
| Formula |
C17H13F3N2O
|
||||
| Canonical SMILES |
C12=C(NC(=C[C@H]1c1cc(C#N)ccc1)C(F)(F)F)CCCC2=O
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Potassium channel | Target Info | Opener | [526383] | |
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.